1. Medtech Insight

Illumina Claps Back At Carl Icahn

 
• By Barnaby Pickering

Carl Icahn has been causing trouble at the sequencing giant, using its muddied merger with Grail as justification for the nomination of three new board members of his choosing.

The bell will not sound in Icahn and Illumina's corporate boxing match until votes are counted. • Source: Shutterstock

The disagreement between legendary corporate raider Carl Icahn and the directors of sequencing technology-developer Illumina has reached a head.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Oncology

More from Device Area